Please login to the form below

Not currently logged in
Email:
Password:

Complaints about UK medical advertising drop

And this year the MHRA will be vetting adverts to promote a ‘right first time’ approach

mhra logoThe Medicines and Healthcare products Regulatory Agency (MHRA)'s annual medical advertising report shows a decrease in complaints received last year.

Although complaints dropped to 193, down from 283 from the previous year, the report entitled 'Delivering high standards in medicines advertising' detailed serious breaches in regulations by healthcare bodies.

Johnson & Johnson filed a complaint to the MHRA concerning a TV advertisement produced by Omega Pharma for Bronchostop, a traditional herbal medicine licensed on the basis of evidence of traditional usage that wrongly suggesting the efficacy of the treatment had been demonstrated.

Another complaint lodged to the MHRA cited a meeting for healthcare professionals, where medicines were promoted and attendees were expected to make a 'minimum' purchase, which is not in line with the law.

Beryl Keeley, head of the MHRA's advertising standards unit, commented: “People have the right to know that the advertisements they see are accurate and do not contain any information that could be misleading and that is why we and the self-regulatory bodies take the action that we do.

“In the coming year, we expect to vet advertising for around 50 products to promote a 'right first time' approach and protect against misleading messages in advertising.”

Complaints to the MHRA are resolved through voluntary agreements, by companies either correcting or removing their adverts without the need for further regulatory action.

Article by
Kirstie Pickering

3rd March 2015

From: Marketing, Regulatory

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
COVID-proof: How Teams are Creating Launch Intensity thru Adversity
Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....